The results have shown that breast cancer cells preferentially express Ki-67 mRNA isoforms with short 3’UTRs, and the expression of shorter Ki-67 mRNAs leads to an increase in Ki-67 mRNA stability and translational efficiency. The gene discussed is MKI67; the disease is breast cancer.